Xiao-ge Liu

Beijing, 100049, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Retraction Note: Superparamagnetic iron oxide nanoparticles conjugated with Aβ oligomer-specific ScFv antibody and class A scavenger receptor activator show therapeutic potentials for alzheimer's disease.

Retraction Note: Superparamagnetic iron oxide nanoparticles conjugated with Aβ oligomer-specific ScFv antibody and class A scavenger receptor activator show therapeutic potentials for alzheimer's disease.

Journal: Journal of nanobiotechnology

Published: November 26, 2025

Histomorphological analysis of perfusion parameters and CNS lymphatic vessels in mice: an experimental method study.

Histomorphological analysis of perfusion parameters and CNS lymphatic vessels in mice: an experimental method study.

Journal: Neuroreport

Published: February 02, 2024

Superparamagnetic iron oxide nanoparticles conjugated with Aβ oligomer-specific scFv antibody and class A scavenger receptor activator show therapeutic potentials for Alzheimer's Disease.

Superparamagnetic iron oxide nanoparticles conjugated with Aβ oligomer-specific scFv antibody and class A scavenger receptor activator show therapeutic potentials for Alzheimer's Disease.

Journal: Journal of nanobiotechnology

Published: June 24, 2020

Yeast-Based Aβ1-15 Vaccine Elicits Strong Immunogenicity and Attenuates Neuropathology and Cognitive Deficits in Alzheimer's Disease Transgenic Mice.

Yeast-Based Aβ1-15 Vaccine Elicits Strong Immunogenicity and Attenuates Neuropathology and Cognitive Deficits in Alzheimer's Disease Transgenic Mice.

Journal: Vaccines

Published: June 06, 2020

Multifunctional Superparamagnetic Iron Oxide Nanoparticles Conjugated with Aβ Oligomer-Specific scFv Antibody and Class A Scavenger Receptor Activator Show Early Diagnostic Potentials for Alzheimer's Disease.

Multifunctional Superparamagnetic Iron Oxide Nanoparticles Conjugated with Aβ Oligomer-Specific scFv Antibody and Class A Scavenger Receptor Activator Show Early Diagnostic Potentials for Alzheimer's Disease.

Journal: International journal of nanomedicine

Published: December 03, 2019

ScFv-conjugated superparamagnetic iron oxide nanoparticles for MRI-based diagnosis in transgenic mouse models of Parkinson's and Huntington's diseases.

ScFv-conjugated superparamagnetic iron oxide nanoparticles for MRI-based diagnosis in transgenic mouse models of Parkinson's and Huntington's diseases.

Journal: Brain research

Published: August 29, 2018

Naturally occurring autoantibodies against α-synuclein rescues memory and motor deficits and attenuates α-synuclein pathology in mouse model of Parkinson's disease.

Naturally occurring autoantibodies against α-synuclein rescues memory and motor deficits and attenuates α-synuclein pathology in mouse model of Parkinson's disease.

Journal: Neurobiology of disease

Published: August 05, 2018

PLGA nanoparticles modified with a BBB-penetrating peptide co-delivering Aβ generation inhibitor and curcumin attenuate memory deficits and neuropathology in Alzheimer's disease mice.

PLGA nanoparticles modified with a BBB-penetrating peptide co-delivering Aβ generation inhibitor and curcumin attenuate memory deficits and neuropathology in Alzheimer's disease mice.

Journal: Oncotarget

Published: May 19, 2017

Showing 1-8 of 8

Last Updated: 09/26/2026